Company / Free Cash Flow
Incyte Free Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$286.6M
FY2024
5-year range
$286.6M / $892.1M
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#29 of 194
Health Care
What the data says
Incyte's free cash flow of $287M is higher than 85% of companies in the Health Care sector (FY2024). Free Cash Flow has fluctuated over the past 8 years, ranging from -$204M in FY2019 to $892M in FY2022.
Based on SEC 10-K filings.
$287M in FY2024 with a 3-year CAGR of -20.4%. Top quartile in the Health Care sector.
Declined from $568M to $287M over the past 3 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -20.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 194This company $286.6M Sector average $470.6M
▼
-39.1% below sector average
Key checks
Key Insights
- 3-year CAGR of -20.4%, indicating a declining trend.
- Ranks #29 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2022.
- Lowest free cash flow in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $286.6M | - |
| FY2023 | - | - |
| FY2022 | $892.1M | +56.9% |
| FY2021 | $568.5M | +116.4% |
| FY2020 | $262.7M | +228.8% |
| FY2019 | -$204.0M | -177.6% |
| FY2018 | $262.7M | +228.8% |
| FY2017 | -$204.0M | -210.6% |
| FY2016 | $184.5M | +191.0% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026